Chlorotoxin conjugate/Cancer

Patent Granted CTX: Cy5.5 bioconjugate which is a combination of chlorotoxin and a fluorescent material named, Cy5.5 has been recently used by Researchers at Seattle Children’s Hospital Research Institute and Fred Hutchinson Cancer Research Center to demarcate cancer cells from the surrounding normal cells.[10] This gives surgeons a better chance of removing all of the cancerous cells without injuring the surrounding healthy tissue. CTX: Cy5.5 is a fluorescent molecule emitting photons in the near infrared spectrum and hence can be visualized in the operating room with the aid of infrared glasses.